Hyperspectral Scanning Laser Ophthalmoscope for Alzheimer's Disease

阿尔茨海默病（AD）通常与神经变性和老年性痴呆的积累相关。 大脑中的斑块神经科医生目前使用放射性标记来可视化斑块的严重程度， 大脑，这是一个耗时，昂贵的过程，并使患者暴露于辐射。最新研究成果 表明样本斑块沉积在位于眼睛后部的视网膜的神经组织中。 博士Sarunic和加拿大公司Optina Diagnostics都在开发新的可视化技术 视网膜中的斑块的最小侵入性，以降低成像的成本， 监测AD患者。 本研究的目的是探讨一种新型的光学成像系统， 高光谱技术用于检测眼睛中的AD斑块。萨鲁尼克博士的研究小组在以下方面经验丰富： 眼科成像系统的发展，并对AD的视网膜诊断感兴趣。这次订婚 该研究项目将促进新的合作，并调查新的医学成像 仪器仪表

Alzheimer's Disease (AD) is commonly associated with neurodegeneration and an accumulation of senile plaques in the brain. Neurologists currently use radioactive labels to visualize the severity of the plaques in the brain, a process that is time consuming, costly, and exposes the patients to radiation. Recent research results suggest that the sample plaques are deposited in the neural tissues of the retina, located at the back of the eye. Dr. Sarunic and Canadian company Optina Diagnostics are each developing novel technology for visualization of the plaques in the retina minimally invasively in anticipation of lowering the costs of imaging and monitoring AD patients. The purpose of this research proposal is to investigate a novel optical imaging system using Optina's hyperspectral technology for detection of AD plaques in the eye. Dr. Sarunic's research group is experienced in the development of ophthalmic imaging systems, and interested in retinal diagnostics for AD. This Engage research project will facilitate a new collaboration, and the investigation of novel medical imaging instrumentation.